Expression of the murine CD27 ligand CD70 in vitro and in vivo - PubMed (original) (raw)
Expression of the murine CD27 ligand CD70 in vitro and in vivo
Kiki Tesselaar et al. J Immunol. 2003.
Abstract
The interaction between TNFR family member CD27 and its ligand CD70 promotes lymphocyte expansion and effector cell formation. In humans, control of CD27 function is partly regulated by the restricted expression of CD70. We used newly developed mAbs to characterize murine (m) CD70 expression in vitro and in vivo. On resting lymphocytes and immature dendritic cells (DC), mCD70 is absent. In vitro, Ag receptor triggering induced mCD70 mRNA in T cells, but cell surface protein expression was very low. Activated B cells synthesized much higher levels of mCD70 mRNA than activated T cells and clearly expressed mCD70 at the cell surface. mCD70 cell surface expression could also be induced on the DC line D1 and on in vitro-generated murine DC upon maturation. In lymphoid organs of naive mice, virtually no mCD70-expressing cells were found, with exception of cells in the thymic medulla, which may be epithelial in origin. However, after intranasal infection with influenza virus, lung-infiltrating T cells and T and B cells in draining lymph nodes expressed mCD70 according to immunohistology. In such activated lymphocytes, mCD70 protein is largely retained intracellularly. Plasma membrane expression of mCD70 was only detectable by flow cytometry on a small proportion of lung-infiltrating T cells and peaked at the height of the primary response. Thus, expression of CD70 in the mouse is highly regulated at the transcriptional and posttranslational level. This most likely serves to limit excessive effector cell formation after antigenic stimulation.
Similar articles
- Characterization of murine CD70 by molecular cloning and mAb.
Oshima H, Nakano H, Nohara C, Kobata T, Nakajima A, Jenkins NA, Gilbert DJ, Copeland NG, Muto T, Yagita H, Okumura K. Oshima H, et al. Int Immunol. 1998 Apr;10(4):517-26. doi: 10.1093/intimm/10.4.517. Int Immunol. 1998. PMID: 9620608 - Characterization of murine CD70, the ligand of the TNF receptor family member CD27.
Tesselaar K, Gravestein LA, van Schijndel GM, Borst J, van Lier RA. Tesselaar K, et al. J Immunol. 1997 Nov 15;159(10):4959-65. J Immunol. 1997. PMID: 9366422 - Signaling through CD70 regulates B cell activation and IgG production.
Arens R, Nolte MA, Tesselaar K, Heemskerk B, Reedquist KA, van Lier RA, van Oers MH. Arens R, et al. J Immunol. 2004 Sep 15;173(6):3901-8. doi: 10.4049/jimmunol.173.6.3901. J Immunol. 2004. PMID: 15356138 - CD27 and CD70 in T cell and B cell activation.
Borst J, Hendriks J, Xiao Y. Borst J, et al. Curr Opin Immunol. 2005 Jun;17(3):275-81. doi: 10.1016/j.coi.2005.04.004. Curr Opin Immunol. 2005. PMID: 15886117 Review. - CD27/CD70 interactions regulate T dependent B cell differentiation.
Jacquot S. Jacquot S. Immunol Res. 2000;21(1):23-30. doi: 10.1385/IR:21:1:23. Immunol Res. 2000. PMID: 10803880 Review.
Cited by
- CD70 contributes to age-associated T cell defects and overwhelming inflammatory responses.
Wang D, Du J, Song Y, Wang B, Song R, Hao Y, Zeng Y, Xiao J, Zheng H, Zeng H, Zhao H, Kong Y. Wang D, et al. Aging (Albany NY). 2020 Jun 19;12(12):12032-12050. doi: 10.18632/aging.103368. Epub 2020 Jun 19. Aging (Albany NY). 2020. PMID: 32559178 Free PMC article. - CD70 expression determines the therapeutic efficacy of expanded human regulatory T cells.
Arroyo Hornero R, Georgiadis C, Hua P, Trzupek D, He LZ, Qasim W, Todd JA, Ferreira RC, Wood KJ, Issa F, Hester J. Arroyo Hornero R, et al. Commun Biol. 2020 Jul 14;3(1):375. doi: 10.1038/s42003-020-1097-8. Commun Biol. 2020. PMID: 32665635 Free PMC article. - Epstein-Barr Virus in Inborn Immunodeficiency-More Than Infection.
Lino CNR, Ghosh S. Lino CNR, et al. Cancers (Basel). 2021 Sep 23;13(19):4752. doi: 10.3390/cancers13194752. Cancers (Basel). 2021. PMID: 34638238 Free PMC article. Review. - CD70 as an actionable immunotherapeutic target in recurrent glioblastoma and its microenvironment.
Seyfrid M, Maich WT, Shaikh VM, Tatari N, Upreti D, Piyasena D, Subapanditha M, Savage N, McKenna D, Mikolajewicz N, Han H, Chokshi C, Kuhlmann L, Khoo A, Salim SK, Archibong-Bassey B, Gwynne W, Brown K, Murtaza N, Bakhshinyan D, Vora P, Venugopal C, Moffat J, Kislinger T, Singh S. Seyfrid M, et al. J Immunother Cancer. 2022 Jan;10(1):e003289. doi: 10.1136/jitc-2021-003289. J Immunother Cancer. 2022. PMID: 35017149 Free PMC article. - ARGX-110, a highly potent antibody targeting CD70, eliminates tumors via both enhanced ADCC and immune checkpoint blockade.
Silence K, Dreier T, Moshir M, Ulrichts P, Gabriels SM, Saunders M, Wajant H, Brouckaert P, Huyghe L, Van Hauwermeiren T, Thibault A, De Haard HJ. Silence K, et al. MAbs. 2014 Mar-Apr;6(2):523-32. doi: 10.4161/mabs.27398. Epub 2013 Dec 6. MAbs. 2014. PMID: 24492296 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous